Min-Hsien Wang

发表

DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity.

C. Chen, Y. Chao, Jen‐Shin Song, 2021, Life sciences.

N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Y. Chao, Szu-Huei Wu, 2016, Bioorganic & medicinal chemistry.

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti‐angiogenic activities

Chi-Hung Lin, C. Chen, Y. Chao, 2011, Cancer science.

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

C. Chen, Chien Ho, Yen-Ju Chen, 2020, Scientific Reports.

Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.

H. Hsieh, C. Chen, Xin Chen, 2006, Bioorganic & medicinal chemistry letters.

Stem cell mobilizers targeting chemokine receptor CXCR4: renoprotective application in acute kidney injury.

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2015, Journal of medicinal chemistry.

Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Y. Chao, Szu-Huei Wu, 2019, Bioorganic chemistry.

Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.

C. Chen, Y. Chao, Szu-Huei Wu, 2018, European journal of medicinal chemistry.

(1,3-Diphenyl-1H-pyrazol-4-yl)-methylamine Analogues as Inhibitors of Dipeptidyl Peptidases

C. Chen, Xin Chen, Y. Chao, 2009 .

Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors.

C. Chen, Xin Chen, Y. Chao, 2009, Bioorganic & medicinal chemistry.

Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.

C. Hsiao, Min-Hsien Wang, Yun-Liang Yang, 2009, Mycological research.

Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.

C. Chen, Y. Chao, Chieh-Jui Hsieh, 2011, Journal of medicinal chemistry.

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

C. Chen, Y. Chao, T. Yeh, 2019, Translational oncology.

(2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV.

C. Chen, Xin Chen, Y. Chao, 2010, Bioorganic & medicinal chemistry letters.

Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors.

C. Chen, Xin Chen, Y. Chao, 2009, Bioorganic & medicinal chemistry letters.

Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type

C. Chen, Wen-Sen Lee, Y. Lai, 2009, Cancer Chemotherapy and Pharmacology.

Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2012, European journal of medicinal chemistry.

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

C. Chen, Chien Ho, Yen-Ju Chen, 2020, Scientific Reports.

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

C. Chen, T. Yeh, Min-Hsien Wang, 2020, Translational oncology.